Cardio Diagnostics Holdings integrates multi-omic data into a proprietary AI platform to analyze molecular profiles for heart health. The tool synthesizes complex biological datasets to improve cardiovascular diagnostic precision. This incremental application of AI to proteomics and genomics provides clinicians with more granular patient data. It targets a niche intersection of biotech and machine learning.